StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.15−0.39 (-4.57%)

Close on Nov 17, 2026Market cap $284.29MP/E –Yield –

Benitec Biopharma r&d expenses

Research and development expenses are spending on new products and technology.

Benitec Biopharma's R&D Expenses for the twelve months ending Jun 30, 2026 was $23.39M, up 27.6% year over year. For fiscal 2026 it was $23.39M, up 27.6% from the year before. The highest annual figure on record is $23.39M in fiscal 2026.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Jun 30, 2026$23.39M+27.6%
FY2025Jun 30, 2025$18.33M+17.4%
FY2024Jun 30, 2024$15.61M+22.2%
FY2023Jun 30, 2023$12.77M+13.3%
FY2022Jun 30, 2022$11.27M+60.6%
FY2021Jun 30, 2021$7.02M+133.9%
FY2020Jun 30, 2020$3.00M-34.3%
FY2019Jun 30, 2019$4.57M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$7.89M+175.1%
Q3 FY2026CQ1 2026Mar 31, 2026$6.30M-3.0%
Q2 FY2026CQ4 2025Dec 31, 2025$5.83M+8.3%
Q1 FY2026CQ3 2025Sep 30, 2025$3.37M-6.0%
Q4 FY2025CQ2 2025Jun 30, 2025$2.87M-18.4%
Q3 FY2025CQ1 2025Mar 31, 2025$6.50M+153.1%
Q2 FY2025CQ4 2024Dec 31, 2024$5.39M+5.5%
Q1 FY2025CQ3 2024Sep 30, 2024$3.59M-19.1%
Q4 FY2024CQ2 2024Jun 30, 2024$3.51M+10.2%
Q3 FY2024CQ1 2024Mar 31, 2024$2.57M-19.0%
Q2 FY2024CQ4 2023Dec 31, 2023$5.10M+35.7%
Q1 FY2024CQ3 2023Sep 30, 2023$4.43M+66.5%
Q4 FY2023CQ2 2023Jun 30, 2023$3.19M+0.3%
Q3 FY2023CQ1 2023Mar 31, 2023$3.17M+45.9%
Q2 FY2023CQ4 2022Dec 31, 2022$3.76M+19.5%
Q1 FY2023CQ3 2022Sep 30, 2022$2.66M-4.3%
Q4 FY2022CQ2 2022Jun 30, 2022$3.18M+36.9%
Q3 FY2022CQ1 2022Mar 31, 2022$2.17M-21.3%
Q2 FY2022CQ4 2021Dec 31, 2021$3.15M+169.3%
Q1 FY2022CQ3 2021Sep 30, 2021$2.78M+259.2%
Q4 FY2021CQ2 2021Jun 30, 2021$2.32M+156.1%
Q3 FY2021CQ1 2021Mar 31, 2021$2.76M+242.6%
Q2 FY2021CQ4 2020Dec 31, 2020$1.17M+95.0%
Q1 FY2021CQ3 2020Sep 30, 2020$774.00K+83.0%
Q4 FY2020CQ2 2020Jun 30, 2020$906.00K–
Q3 FY2020CQ1 2020Mar 31, 2020$805.00K–
Q2 FY2020CQ4 2019Dec 31, 2019$599.00K–
Q1 FY2020CQ3 2019Sep 30, 2019$423.00K–

More Benitec Biopharma figures

See a number that looks wrong?